RTW Biotech holding Obsidian goes public in reverse merger

The £783m biotech trust has seen another holding move to the listed market as the sector gears up for record M&A activity this year.
The £783m biotech trust has seen another holding move to the listed market as the sector gears up for record M&A activity this year.